Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study

F (Franco) Locatelli; C Mauz-Koerholz; K Neville; A Llort; Auke Beishuizen; S Daw; M Pillon; N Aladjidi; T Klingebiel; J Landman-Parker; A Medina-Sanson; K August; J Sachs; K Hoffman; J Kinley; S Song; G Song; S Zhang; A Suri; L Gore

Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study

F (Franco) Locatelli
, C Mauz-Koerholz
, K Neville
, A Llort
, Auke Beishuizen
, S Daw
, M Pillon
, N Aladjidi
, T Klingebiel
, J Landman-Parker
, A Medina-Sanson
, K August
, J Sachs
, K Hoffman
, J Kinley
, S Song
, G Song
, S Zhang
, A Suri
, L Gore

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

93 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E450-E461
Journal	Lancet Haematology
Volume	5
Issue number	10
Publication status	Published - 2018

Research programs

EMC MM-02-54-03

Cite this

Locatelli, F., Mauz-Koerholz, C., Neville, K., Llort, A., Beishuizen, A., Daw, S., Pillon, M., Aladjidi, N., Klingebiel, T., Landman-Parker, J., Medina-Sanson, A., August, K., Sachs, J., Hoffman, K., Kinley, J., Song, S., Song, G., Zhang, S., Suri, A., & Gore, L. (2018). Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. Lancet Haematology, 5(10), E450-E461.

@article{27a7a5b480f44a18aa99e8fc97e1c5fb,

title = "Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study",

author = "Locatelli, \{F (Franco)\} and C Mauz-Koerholz and K Neville and A Llort and Auke Beishuizen and S Daw and M Pillon and N Aladjidi and T Klingebiel and J Landman-Parker and A Medina-Sanson and K August and J Sachs and K Hoffman and J Kinley and S Song and G Song and S Zhang and A Suri and L Gore",

year = "2018",

language = "Undefined/Unknown",

volume = "5",

pages = "E450--E461",

journal = "Lancet Haematology",

issn = "2352-3026",

publisher = "Elsevier Ltd.",

number = "10",

}

Locatelli, F, Mauz-Koerholz, C, Neville, K, Llort, A, Beishuizen, A, Daw, S, Pillon, M, Aladjidi, N, Klingebiel, T, Landman-Parker, J, Medina-Sanson, A, August, K, Sachs, J, Hoffman, K, Kinley, J, Song, S, Song, G, Zhang, S, Suri, A & Gore, L 2018, 'Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study', Lancet Haematology, vol. 5, no. 10, pp. E450-E461.

TY - JOUR

T1 - Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study

AU - Locatelli, F (Franco)

AU - Mauz-Koerholz, C

AU - Neville, K

AU - Llort, A

AU - Beishuizen, Auke

AU - Daw, S

AU - Pillon, M

AU - Aladjidi, N

AU - Klingebiel, T

AU - Landman-Parker, J

AU - Medina-Sanson, A

AU - August, K

AU - Sachs, J

AU - Hoffman, K

AU - Kinley, J

AU - Song, S

AU - Song, G

AU - Zhang, S

AU - Suri, A

AU - Gore, L

PY - 2018

Y1 - 2018

M3 - Article

SN - 2352-3026

VL - 5

SP - E450-E461

JO - Lancet Haematology

JF - Lancet Haematology

IS - 10

ER -